Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 153 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1521 7.1 months Inoperable hepatocellular carcinoma 4 Chemotherapy
Sungkyunkwan University School of Medicine Korea 4/2009
Treatment Details: Patients: This study involved 32 patients with inoperable hepatocellular carcinoma (liver cancer). The majority (26) were men. The median age was 50, ranging from 33 to 67 years old. T
 
1522 7.1 months Metastatic colorectal carcinoma 5 Biologic therapy
University of California, Los Angeles United States 4/2010
Treatment Details: Patients: This study involved metastatic colorectal cancer patients who were divided into two separate patient groups based on the level of the epidermal growth factor receptor (EGFR) prote
 
1523 7.1 months Recurrent GBM 4 Università Politecnica delle Marche Italy 4/2013
Treatment Details: Patients: This study involved 65 elderly (at least 65 years old) recurrent glioblastoma patients who had been previously treated. The median patient age was 70 years and 35 were male. T
 
1524 7.1 months Metastatic urothelial carcinoma 5 Biologic therapy
Memorial Sloan-Kettering Cancer Center United States 2/2010
Treatment Details: Patients: This phase II trial involved 45 previously-treated metastatic urothelial cancer patients with a median age of 64 years; 71% were male. Treatment: Patients were treated with th
 
1525 7.1 months Hepatocellular carcinoma 4 Chemotherapy
Sungkyunkwan University School of Medicine Korea 4/2009
Treatment Details: Patients: This phase 2 study involved 32 inoperable hepatocellular carcinoma patients who had not received prior systemic chemotherapy. The median patient age was 50 years and 81% were mal
 
1526 7.1 months Advanced Liver Cancer 4 Biologic therapy
Princess Margaret Cancer Centre Canada 1/2015
Treatment Details:  Patients: This phase 2 study involved 30 previously treated advanced hepatocellular carcinoma patients. The median patient age was 64 years and 70% were male. Treatment: Patients rec
 
1527 7.1 months Metastatic Colorectal Cancer 3 Chemotherapy
Hallym University Medical Center Korea 1/2015
Treatment Details: Patients: This phase 2 study involved 25 previously treated metastatic colorectal cancer patients. The median patient age was 61 years and 48% were male. Treatment: Patients received c
 
1528 7.1 months Metastatic Colorectal Cancer 5 Chemotherapy
Dana–Farber Cancer Institute United States 5/2015
Treatment Details: Patients: This phase 3 study involved 534 previously treated metastatic colorectal cancer patients. The median patient age was 63 years and 61% were male. Treatment: Patients received
 
1529 7.1 months Metastatic Colorectal Cancer 5 Biologic therapy
Hospital Clinico San Carlos Spain 7/2015
Treatment Details: Patients: This phase 2 study involved 33 frail, elderly, wild-type KRAS metastatic colorectal cancer patients. The median patient age was 81 years (range 73-89) and 66.7% were male. Tre
 
1530 7.1 months Malignant Pleural Mesothelioma 5 Memorial Sloan Kettering Cancer Center United States 4/2015
Treatment Details: Patients: This phase 3 study involved 329 previously treated, advanced malignant pleural mesothelioma patients. The median patient age was 64 years and 86% were male. Treatment: Patien
 
Page 153 of 187  | Previous Page  | Next Page